FGFR3 contributes to intestinal crypt cell growth arrest

Sandrine Arnaud-Dabernat, Deepak Yadav, Nora E Sarvetnick

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Fibroblast growth factors (FGFs) are important regulators of the dynamic development and turnover of tissues. Among FGF receptors, FGFR3 expression is confined in the intestinal crypts. We examined FGFR3-deficient mice and saw increased intestinal crypt depth but no change in villae length or in the distribution of differentiated intestinal cells, suggesting that the impact of lack of FGFR3 was limited to the progenitor cell compartment. Accordingly, enhancement of intestinal crypt proliferation was observed in FGFR3 mutant mice and interestingly, upon anti-FGFR3 antibody administration in wild type mice. Moreover, injection of FGF18, a ligand of FGFR3, in wild type mice resulted in decreased cell proliferation within the intestinal crypts. Inaddition, we found that ERK level of activation was increased in FGFR3-deficient intestinal epithelium. In vitro studies showed that ERK, AKT and activation was regulated by FGFs and that ERK level of activation was inversely correlated to FGFR3 level of expression in the intestinal crypt cells. Furthermore, effects of FGF18 on ERK and AKT activation paralleled FGFR3 effects on these intracellular targets. Our data indicate that FGF18 and FGFR3 are involved, possibly as partners, in the control of intestinal precursor cell proliferation.

Original languageEnglish (US)
Pages (from-to)261-268
Number of pages8
JournalJournal of Cellular Physiology
Volume216
Issue number1
DOIs
StatePublished - Jan 1 2008

Fingerprint

Cell growth
Chemical activation
Fibroblast Growth Factors
Cell proliferation
Growth
Cell Proliferation
Fibroblast Growth Factor Receptors
Intestinal Mucosa
Anti-Idiotypic Antibodies
Stem Cells
Tissue
Ligands
Injections
Antibodies

ASJC Scopus subject areas

  • Physiology
  • Clinical Biochemistry
  • Cell Biology

Cite this

FGFR3 contributes to intestinal crypt cell growth arrest. / Arnaud-Dabernat, Sandrine; Yadav, Deepak; Sarvetnick, Nora E.

In: Journal of Cellular Physiology, Vol. 216, No. 1, 01.01.2008, p. 261-268.

Research output: Contribution to journalArticle

Arnaud-Dabernat, Sandrine ; Yadav, Deepak ; Sarvetnick, Nora E. / FGFR3 contributes to intestinal crypt cell growth arrest. In: Journal of Cellular Physiology. 2008 ; Vol. 216, No. 1. pp. 261-268.
@article{81087866bf1847d9a3f3d8b2a2ca4ab2,
title = "FGFR3 contributes to intestinal crypt cell growth arrest",
abstract = "Fibroblast growth factors (FGFs) are important regulators of the dynamic development and turnover of tissues. Among FGF receptors, FGFR3 expression is confined in the intestinal crypts. We examined FGFR3-deficient mice and saw increased intestinal crypt depth but no change in villae length or in the distribution of differentiated intestinal cells, suggesting that the impact of lack of FGFR3 was limited to the progenitor cell compartment. Accordingly, enhancement of intestinal crypt proliferation was observed in FGFR3 mutant mice and interestingly, upon anti-FGFR3 antibody administration in wild type mice. Moreover, injection of FGF18, a ligand of FGFR3, in wild type mice resulted in decreased cell proliferation within the intestinal crypts. Inaddition, we found that ERK level of activation was increased in FGFR3-deficient intestinal epithelium. In vitro studies showed that ERK, AKT and activation was regulated by FGFs and that ERK level of activation was inversely correlated to FGFR3 level of expression in the intestinal crypt cells. Furthermore, effects of FGF18 on ERK and AKT activation paralleled FGFR3 effects on these intracellular targets. Our data indicate that FGF18 and FGFR3 are involved, possibly as partners, in the control of intestinal precursor cell proliferation.",
author = "Sandrine Arnaud-Dabernat and Deepak Yadav and Sarvetnick, {Nora E}",
year = "2008",
month = "1",
day = "1",
doi = "10.1002/jcp.21401",
language = "English (US)",
volume = "216",
pages = "261--268",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - FGFR3 contributes to intestinal crypt cell growth arrest

AU - Arnaud-Dabernat, Sandrine

AU - Yadav, Deepak

AU - Sarvetnick, Nora E

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Fibroblast growth factors (FGFs) are important regulators of the dynamic development and turnover of tissues. Among FGF receptors, FGFR3 expression is confined in the intestinal crypts. We examined FGFR3-deficient mice and saw increased intestinal crypt depth but no change in villae length or in the distribution of differentiated intestinal cells, suggesting that the impact of lack of FGFR3 was limited to the progenitor cell compartment. Accordingly, enhancement of intestinal crypt proliferation was observed in FGFR3 mutant mice and interestingly, upon anti-FGFR3 antibody administration in wild type mice. Moreover, injection of FGF18, a ligand of FGFR3, in wild type mice resulted in decreased cell proliferation within the intestinal crypts. Inaddition, we found that ERK level of activation was increased in FGFR3-deficient intestinal epithelium. In vitro studies showed that ERK, AKT and activation was regulated by FGFs and that ERK level of activation was inversely correlated to FGFR3 level of expression in the intestinal crypt cells. Furthermore, effects of FGF18 on ERK and AKT activation paralleled FGFR3 effects on these intracellular targets. Our data indicate that FGF18 and FGFR3 are involved, possibly as partners, in the control of intestinal precursor cell proliferation.

AB - Fibroblast growth factors (FGFs) are important regulators of the dynamic development and turnover of tissues. Among FGF receptors, FGFR3 expression is confined in the intestinal crypts. We examined FGFR3-deficient mice and saw increased intestinal crypt depth but no change in villae length or in the distribution of differentiated intestinal cells, suggesting that the impact of lack of FGFR3 was limited to the progenitor cell compartment. Accordingly, enhancement of intestinal crypt proliferation was observed in FGFR3 mutant mice and interestingly, upon anti-FGFR3 antibody administration in wild type mice. Moreover, injection of FGF18, a ligand of FGFR3, in wild type mice resulted in decreased cell proliferation within the intestinal crypts. Inaddition, we found that ERK level of activation was increased in FGFR3-deficient intestinal epithelium. In vitro studies showed that ERK, AKT and activation was regulated by FGFs and that ERK level of activation was inversely correlated to FGFR3 level of expression in the intestinal crypt cells. Furthermore, effects of FGF18 on ERK and AKT activation paralleled FGFR3 effects on these intracellular targets. Our data indicate that FGF18 and FGFR3 are involved, possibly as partners, in the control of intestinal precursor cell proliferation.

UR - http://www.scopus.com/inward/record.url?scp=44449172548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44449172548&partnerID=8YFLogxK

U2 - 10.1002/jcp.21401

DO - 10.1002/jcp.21401

M3 - Article

VL - 216

SP - 261

EP - 268

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 1

ER -